Loading...
Loading...
Among the 7 tracked institutional investors we monitor, TNXP (TONIX PHARMACEUTICALS HLDG C) is held with a combined value of $38.81M across 2,731,026 shares. The largest holder is BlackRock, Inc. with a position worth $13.31M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$38.81M
Total Shares Held
2,731,026
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $13.31M | 0.00% | +9.4% |
| 2 | VANGUARD GROUP INC | $10.52M | 0.00% | New |
| 3 | CITADEL ADVISORS LLC | $7.04M | 0.00% | +1186.0% |
| 4 | STATE STREET CORP | $3.17M | 0.00% | +20.2% |
| 5 | MILLENNIUM MANAGEMENT LLC | $3.02M | 0.00% | +857.3% |
| 6 | Point72 Asset Management, L.P. | $1.72M | 0.00% | -79.8% |
| 7 | FMR LLC | $23.90K | 0.00% | +15.6% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of TNXP with a position worth $13.31M, representing 0.00% of their portfolio. In total, 7 institutional investors hold TNXP with a combined value of $38.81M.
In the most recent quarter, 1 fund opened a new position in TNXP. Additionally, 5 increased their holdings and 1 reduced their positions.
Institutional investors hold $38.81M worth of TNXP stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $13.31M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TNXP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TNXP positions.